FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Spencer Pharmaceutical Inc. Stock AnalysisComprehensive stock analysis for Spencer Pharmaceutical Inc. (SPPH) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSPPH
SPPH
Spencer Pharmaceutical Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SPPH
Home🔹Stocks🔹Spencer Pharmaceutical Inc.

Spencer Pharmaceutical Inc.

SPPH•OTC

Spencer Pharmaceutical Inc.

SPPH•OTC
Market cap
$29.44K
Sentiment

Your view on SPPH

Mkt Cap
$29.44K
Sentiment
Your view
SPPH
Spencer Pharmaceutical Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SPPH
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Spencer Pharmaceutical Inc.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Maximilien Arella
Headquarters
8 Faneuil Hall Marketplace, Boston, US
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Maximilien Arella
Headquarters
8 Faneuil Hall Marketplace, Boston, US
Description

Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, Massachusetts.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News